New combo therapy targets liver tumors in colorectal cancer patients
NCT ID NCT03223779
First seen Nov 01, 2025 · Last updated May 27, 2026 · Updated 27 times
Summary
This study looked at combining a chemotherapy pill (TAS-102) with targeted radiation to treat colorectal cancer that has spread to the liver. It involved 52 adults with 1 to 4 liver tumors. The goal was to find the safest dose and see how well the combination controls tumor growth.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.